8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Apr 18, 2006)

Filed April 18, 2006For Securities:BSX

Summary

This Form 8-K filing by Boston Scientific Corporation (BSX) on April 18, 2006, primarily serves to furnish a press release announcing the company's financial results for the first quarter ended March 31, 2006. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for these operational and financial condition updates. Investors should refer to the press release for specific details regarding revenue, earnings, and any other key performance indicators for the first quarter of 2006. This filing indicates that important financial information has been disseminated by the company and is available for public review, marking a standard disclosure event for quarterly earnings.

Key Highlights

  • 1Boston Scientific Corporation (BSX) filed a Form 8-K on April 18, 2006.
  • 2The filing's primary purpose is to announce the company's financial results for the first quarter ended March 31, 2006.
  • 3The detailed financial results are provided in an accompanying press release, furnished as Exhibit 99.1.
  • 4This report contains information related to 'Results of Operations and Financial Condition' under Item 2.02.
  • 5The information furnished is not deemed 'filed' for purposes of Section 18 of the Exchange Act, but is incorporated by reference into this filing.
  • 6The filing also lists Exhibit 99.1 (Press Release dated April 18, 2006) under Item 9.01.
  • 7The report was signed by Lawrence J. Knopf, Vice President and Assistant General Counsel.

Frequently Asked Questions

The main purpose of this Form 8-K filing by Boston Scientific on April 18, 2006, is to officially announce the company's financial results for the first quarter ended March 31, 2006, by furnishing a related press release.

The detailed financial results for the first quarter ended March 31, 2006, are contained within the press release issued by Boston Scientific on April 18, 2006, which is provided as Exhibit 99.1 to this Form 8-K filing.

This specific 8-K filing does not contain the detailed financial data itself. Instead, it references a press release (Exhibit 99.1) that was issued on the same date to disclose the company's Q1 2006 financial results. Investors should consult that press release for specifics.

When information is furnished and not deemed 'filed' under Section 18 of the Exchange Act, it means that the company is providing the information to the SEC, but it does not carry the same legal liabilities associated with information that is officially 'filed' for purposes of liability under that section. However, it is still considered important disclosure for investors.